RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mayer Davidson to Cohort Studies

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Cohort Studies.
Mayer Davidson
Connection Strength
0.346
Cohort Studies
  1. Davidson MB. SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists. Ann Intern Med. 2019 12 17; 171(12):JC70.
    View in: PubMed
    Score: 0.136
  2. Davidson MB, Pan D. An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. Diabetes Res Clin Pract. 2018 Jan; 135:102-110.
    View in: PubMed
    Score: 0.118
  3. Davidson MB, Pan D. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support